World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
55
Citations
11188
World Ranking
15031
National Ranking
6289

David B. Olsen publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where David B. Olsen sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 188 publications — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

David B. Olsen D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where David B. Olsen sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 55 D-Index — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

David B. Olsen is affiliated with MSD (United States) and conducts research mainly within the field of Medicine, with a significant focus on Infectious Diseases, Epidemiology, Public Health, Environmental and Occupational Health, Molecular Biology, and Computational Theory and Mathematics.

The scientist's research covers several major topics, including:

  • Malaria Research and Control
  • Computational Drug Discovery Methods
  • Tuberculosis Research and Epidemiology
  • SARS-CoV-2 and COVID-19 Research
  • Mycobacterium research and diagnosis
  • SARS-CoV-2 detection and testing
  • Trypanosoma species research and implications

Olsen has contributed to multiple publications across frequent venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • ACS Infectious Diseases
  • Antimicrobial Agents and Chemotherapy
  • SSRN Electronic Journal
  • PLoS Pathogens

Some recent papers authored or co-authored by Olsen include:

  • SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development (2021, PLoS Pathogens)
  • Dual Plasmepsin-Targeting Antimalarial Agents Disrupt Multiple Stages of the Malaria Parasite Life Cycle (2020, Cell Host & Microbe)
  • Generation of SARS-CoV-2 reporter replicon for high-throughput antiviral screening and testing (2021, Proceedings of the National Academy of Sciences)
  • The Tuberculosis Drug Accelerator at year 10: what have we learned? (2021, Nature Medicine)
  • Basis for drug selectivity of plasmepsin IX and X inhibition in Plasmodium falciparum and vivax (2022, Structure)

Frequent co-authors collaborating with Olsen include:

  • Nicholas Murgolo
  • John A. McCauley
  • Christopher W. Boyce
  • Anna Ngo
  • Alan F. Cowman

Best Publications

  • Kinetic characterization of ribonuclease-resistant 2'-modified hammerhead ribozymes.

    Wolfgang A. Pieken;David B. Olsen;Fritz Benseler;Helle Aurup

  • L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase.

    S D Young;S F Britcher;L O Tran;L S Payne

  • Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs

    Steven S. Carroll;Joanne E. Tomassini;Michele Bosserman;Krista Getty

  • Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro

    Giovanni Migliaccio;Joanne E. Tomassini;Steven S. Carroll;Licia Tomei

  • Nukleosiidhend, seda sisaldav farmatseutiline kompositsioon ning hendi kasutamine viiruse RNA-s?ltuva RNA polmeraasi inhibiitorina toimiva ravimi valmistamiseks

    Carroll Steven S;Maccoss Malcolm;Olsen David B;Bhat Balkrishen

  • MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants

    Vincenzo Summa;Steven W. Ludmerer;John A. McCauley;Christine Fandozzi

  • A 7-Deaza-Adenosine Analog Is a Potent and Selective Inhibitor of Hepatitis C Virus Replication with Excellent Pharmacokinetic Properties

    David B. Olsen;Anne B. Eldrup;Linda Bartholomew;Balkrishen Bhat

  • Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase

    Anne B Eldrup;Charles R Allerson;C Frank Bennett;Sanjib Bera

  • Discovery of MK-8742: an HCV NS5A inhibitor with broad genotype activity.

    Craig A. Coburn;Peter T. Meinke;Wei Chang;Christine M. Fandozzi

  • Structure−Activity Relationship of Heterobase-Modified 2‘-C-Methyl Ribonucleosides as Inhibitors of Hepatitis C Virus RNA Replication

    Anne B Eldrup;Marija Prhavc;Jennifer Brooks;Balkrishen Bhat

  • Human Monoclonal Antibody HCV1 Effectively Prevents and Treats HCV Infection in Chimpanzees

    Trevor J. Morin;Teresa J. Broering;Brett A. Leav;Barbara M. Blair;Barbara M. Blair;Barbara M. Blair

  • Hcv ns3 protease inhibitors

    M. Katharine Holloway;Nigel J. Liverton;Steven W. Ludmerer;John A. Mccauley

  • Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor

    John A. McCauley;Charles J. McIntyre;Michael T. Rudd;Kevin T. Nguyen

  • Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor.

    Steven Harper;John A McCauley;Michael T Rudd;Marco Ferrara

  • Inhibition of HIV-1 ribonuclease H by a novel diketo acid, 4-[5-(benzoylamino)thien-2-yl]-2,4-dioxobutanoic acid.

    Cathryn A. Shaw-Reid;Vandna Munshi;Pia Graham;Abigail Wolfe

  • SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development.

    Nicholas Murgolo;Alex G. Therien;Bonnie Howell;Daniel Klein

  • Recombinant microbial systems for the production of human collagen and gelatin.

    Julio Báez;David Olsen;James W. Polarek

  • Replication Fitness and NS5B Drug Sensitivity of Diverse Hepatitis C Virus Isolates Characterized by Using a Transient Replication Assay

    Steven W. Ludmerer;Donald J. Graham;Evelyn Boots;Edward M. Murray

  • Characterization of the Inhibition of Hepatitis C Virus RNA Replication by Nonnucleosides

    Licia Tomei;Sergio Altamura;Linda Bartholomew;Monica Bisbocci

  • Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4A protease.

    Nigel J Liverton;M Katharine Holloway;John A McCauley;Michael T Rudd

Frequent Co-Authors

Malcolm Maccoss
Malcolm Maccoss MSD (United States)
Joseph P. Vacca
Joseph P. Vacca MSD (United States)
Fritz Eckstein
Fritz Eckstein Max Planck Society
Daria J. Hazuda
Daria J. Hazuda MSD (United States)
Sheo B. Singh
Sheo B. Singh MSD (United States)
Kevin T. Chapman
Kevin T. Chapman MSD (United States)
Ian W. Davies
Ian W. Davies Princeton University
Michael Rowley
Michael Rowley Pharmaron (United Kingdom)
Phillip Dan Cook
Phillip Dan Cook Ionis Pharmaceuticals (United States)
Kari I. Kivirikko
Kari I. Kivirikko University of Oulu

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring Biology and Biochemistry in the USA can open doors to a wide range of rewarding careers in healthcare, research, and beyond. Many students look for flexible online degrees to fast-track their professional journey and meet ever-growing industry demands.

For those with a nursing background, rn to bsn online programs offer an accessible way to advance clinical knowledge and expand career opportunities. Likewise, individuals aiming for leadership roles might consider the fastest online mha to gain expert skills in healthcare management.

If your interests lie in mental health, specialized pathways like pmhnp programs can prepare you for a career as a Psychiatric Mental Health Nurse Practitioner. Meanwhile, those passionate about wellness and nutrition can benefit from a fast track nutrition degree online, equipping graduates to help individuals and communities live healthier lives.

Overall, these flexible online options make it easier to pursue advanced education and specialized careers alongside your interest in Biology and Biochemistry.

Best Scientists Citing David B. Olsen

Trending Scientists

Recently Published Articles